GleamWall
中文EN

BMY BRISTOL MYERS SQUIBB CO

Pharmaceutical Preparations · NYSE · SEC CIK 14272 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.2%
TTM net income YoY53.1%
TTM EPS YoY51.9%
Revenue 3-yr CAGR3.6%
Net income 3-yr CAGR3.7%

Margins

Gross margin69.2%
Operating margin—
Net margin18.5%
FCF margin18.6%
EBITDA margin—

Returns

ROE44.1%
ROA10.0%
ROIC (approx.)—
Asset turnover0.54x

Leverage & solvency

Liabilities / assets73.6%
Debt / equity1.83x
Current ratio1.59x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.15x
Accruals ratio-1.5%
Payout ratio55.4%
Capex / revenue2.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$48.19B$48.30B
Cost of revenue$13.94B$13.97B
Gross profit$34.26B$34.33B
R&D expense$9.95B$11.16B
SG&A expense$7.27B$8.41B
Interest expense$1.89B$1.95B
Pretax income$9.33B-$8.38B
Income tax$2.27B$554.00M
Net income$7.05B-$8.95B
EPS (basic)3.47-4.41
EPS (diluted)3.46-4.41
Dividends declared per share2.492.42
Weighted avg. shares (diluted)2.04B2.03B
Balance sheet
Cash & equivalents$10.21B$10.35B
Short-term investments$464.00M$513.00M
Receivables$9.59B$9.01B
Inventory$2.69B$2.56B
Current assets$29.39B$29.78B
PP&E, net$7.54B$7.14B
Goodwill$21.75B$21.72B
Intangibles$19.10B$23.31B
Total assets$90.04B$92.60B
Current liabilities$23.42B$23.77B
Short-term debt$2.26B$2.05B
Long-term debt$42.85B$47.60B
Total debt$45.11B$49.65B
Total liabilities$71.53B$76.22B
Shareholders' equity$18.47B$16.34B
Net debt$34.90B$39.30B
Cash flow statement
Operating cash flow$14.16B$15.19B
Capital expenditure$1.31B$1.25B
Free cash flow$12.85B$13.94B
Investing cash flow-$4.13B-$21.35B
Financing cash flow-$10.35B$5.13B
Depreciation & amortization$4.01B$9.60B
Stock-based compensation$553.00M$507.00M
Dividends paid$5.04B$4.86B
Share buybacks$0$0

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.